Pharmaceutical, healthcare, and nutrition company in S.E. Asia, (stellar-kalbefarma.digital) Issuser Address: GDWNCEVHMWCO7V4MSHMWGGRE7PYU4KMYBROP2R7FEGIGC4MGKREBKHWI ICO On 31/10/2023 CB:5,000%
Project Aurora & Ukaz asset
Kalbe is the largest publicly listed pharmaceutical, healthcare, and nutrition company in Southeast Asia and has expanded by strategically acquiring pharmaceutical companies and becoming an integrated consumer health and nutrition enterprise. Its four main divisions are: prescription pharmaceuticals, consumer health products, nutritionals, and distribution & logistics
Prescription Pharmaceutical: offers generic drugs, branded generics, and licensed drugs, which are distributed to hospitals, pharmacies, and drug stores
Consumer Health: over-the-counter drugs, consumer products, food supplements, preventive products, energy drinks, and healthy ready-to-drink products
Nutritionals: biscuits, cereals, and milk products for infants, toddlers, children, pre-teenagers, adults, expectant and lactating mothers, and elderly; as well as nutritional products for consumers with special medical needs
Distribution and Logistic: maintains distribution of the company's and third party principal's products across Indonesia; trading of raw material, medical devices, and retail health service
Kalbe also supports several successful R&D ventures working on cancer drugs, stem cells, and biotechnology research
For example, on 23 October 2023, KGbio (the JV between Kalbe and Korean biopharmaceutical company Genexine) received market approval for treating chronic kidney disease induced anemia in non-dialysis patients. Anemia is the deficiency of healthy red blood cells (RBCs) in blood. RBCs are essential to carry oxygen to all parts of the body, thus having anemia can cause tiredness, weakness, and shortness of breath. Because there are many forms of anemia, it is often known as a warning sign of a more serious illness(es). Producing and maintaining healthy RBCs is one way to protect the body and keep it in optimal condition
Apart from Kalbe Farma, the Setiawan family also controls Jakarta-listed Mitra Keluarga Karyasehat, which operates a chain of 26 hospitals across Jakarta, West Java and Banten
By partnering with and integrating Big Pharma and Biotech databases, Kalbe is another quintessential player in the future of quantum healthcare where Open Source, Generative ML algorithms will more accurately monitor, diagnose, and recommend effective treatments to patients through quantum wearable technology in order to help extend the positive, long term effects of medbed healing
Stellar Humanitarian Wealth Transfer:
? Passive Income Assets (https://t.me/QuantumStellarInitiative/22968)
? Project Aurora & Ukaz (https://t.me/QuantumStellarInitiative/21777)
| Health Care |
Pharmaceutical |